title: Guidelines for acromegaly management.
authors.affiliation: Cedars-Sinai Research Institute-UCLA School of Medicine, Los Angeles, California 90048, USA. melmed@csmc.edu
authors.forename: S
authors.initials: S
authors.lastname: Melmed
authors.forename: F F
authors.initials: FF
authors.lastname: Casanueva
authors.forename: F
authors.initials: F
authors.lastname: Cavagnini
authors.forename: P
authors.initials: P
authors.lastname: Chanson
authors.forename: L
authors.initials: L
authors.lastname: Frohman
authors.forename: A
authors.initials: A
authors.lastname: Grossman
authors.forename: K
authors.initials: K
authors.lastname: Ho
authors.forename: D
authors.initials: D
authors.lastname: Kleinberg
authors.forename: S
authors.initials: S
authors.lastname: Lamberts
authors.forename: E
authors.initials: E
authors.lastname: Laws
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: M L
authors.initials: ML
authors.lastname: Vance
authors.forename: K Von
authors.initials: KV
authors.lastname: Werder
authors.forename: J
authors.initials: J
authors.lastname: Wass
authors.forename: A
authors.initials: A
authors.lastname: Giustina
mesh_terms: D000172:Acromegaly / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D018491:Dopamine Agonists / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000209:etiology* / Q000532:radiotherapy
chemical_list: D018491:Dopamine Agonists